Published in BMJ on December 03, 2009
Thromboembolic Complications and Prophylaxis Patterns in Colorectal Surgery. JAMA Surg (2015) 2.40
Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study. BMC Med (2011) 1.89
Postoperative enoxaparin prevents symptomatic venous thromboembolism in high-risk plastic surgery patients. Plast Reconstr Surg (2011) 1.65
Identifying patients at high risk for venous thromboembolism requiring treatment after outpatient surgery. Ann Surg (2012) 1.55
Validation of the Caprini risk assessment model in plastic and reconstructive surgery patients. J Am Coll Surg (2010) 1.47
Recent respiratory infection and risk of venous thromboembolism: case-control study through a general practice database. Int J Epidemiol (2011) 1.09
Epidemiology of venous thromboembolism. Nat Rev Cardiol (2015) 1.07
The epidemiology of venous thromboembolism. J Thromb Thrombolysis (2016) 1.00
A validated risk model to predict 90-day VTE events in postsurgical patients. Chest (2014) 0.99
Population-based cohort study comparing 30- and 90-day institutional mortality rates after colorectal surgery. Br J Surg (2013) 0.96
Guidance for the treatment of deep vein thrombosis and pulmonary embolism. J Thromb Thrombolysis (2016) 0.96
Venous thromboembolism risk factor assessment and prophylaxis. Phlebology (2010) 0.92
Perioperative pharmacologic prophylaxis for venous thromboembolism in colorectal surgery. J Am Coll Surg (2011) 0.89
Venous thromboembolism in colorectal surgery: skip SCIP or comply? Tech Coloproctol (2014) 0.86
Temporal changes in deep venous thrombosis risk after electrical injury. J Burn Care Res (2011) 0.84
Infection and venous thromboembolism in patients undergoing colorectal surgery: what is the relationship? Dis Colon Rectum (2014) 0.84
Stratifying the risk of venous thromboembolism in otolaryngology. Otolaryngol Head Neck Surg (2012) 0.83
Antidepressants, Depression, and Venous Thromboembolism Risk: Large Prospective Study of UK Women. J Am Heart Assoc (2017) 0.82
Systematic reviews of observational studies of risk of thrombosis and bleeding in urological surgery (ROTBUS): introduction and methodology. Syst Rev (2014) 0.81
Risk of Post-Discharge Venous Thromboembolism and Associated Mortality in General Surgery: A Population-Based Cohort Study Using Linked Hospital and Primary Care Data in England. PLoS One (2015) 0.81
Fast-track surgery in gynaecology and gynaecologic oncology: a review of a rolling clinical audit. ISRN Surg (2012) 0.79
Prevention of postoperative venous thromboembolism. BMJ (2009) 0.77
Using multiple sources of data for surveillance of postoperative venous thromboembolism among surgical patients treated in Department of Veterans Affairs hospitals, 2005-2010. Thromb Res (2015) 0.76
Defining high risk: cost-effectiveness of extended-duration thromboprophylaxis following major oncologic abdominal surgery. J Gastrointest Surg (2013) 0.75
PROPHYLAXIS OF VENOUS THROMBOEMBOLISM IN ORTHOPAEDIC SURGERY. Rev Bras Ortop (2015) 0.75
Postoperative thromboembolism. Prolonged prophylaxis for all? BMJ (2010) 0.75
Prescription of extended-duration thromboprophylaxis after high-risk, abdominopelvic cancer surgery. Gynecol Oncol (2016) 0.75
Are we missing post-thrombotic syndrome syndrome? An orthopaedic perspective in lower limb arthroplasty. Thrombosis (2011) 0.75
Post-operative thromboprophylaxis: new oral thrombin and factor X inhibitors and their place in clinical practice. F1000 Med Rep (2010) 0.75
Prophylaxis of venous thromboembolism in general surgery: guidelines differ and we still need local policies. Ann R Coll Surg Engl (2011) 0.75
Ensuring timely thromboprophylaxis on a Medical Assessment Unit. BMJ Qual Improv Rep (2016) 0.75
IT-CARES: an interactive tool for case-crossover analyses of electronic medical records for patient safety. J Am Med Inform Assoc (2016) 0.75
Pulmonary embolism in non-brain tumor patients after surgery-a retrospective study in China. World J Surg Oncol (2017) 0.75
ACP Journal Club. Risk for postoperative venous thromboembolism in women was increased for > or = 12 weeks and varied by type of surgery. Ann Intern Med (2010) 0.75
[Risk and duration of high risk period for postoperative thromboembolism in middle-aged women is substantial]. Praxis (Bern 1994) (2010) 0.75
Prolonged and increased postoperative risk of venous thromboembolism: rationale for even more 'extended' prophylaxis? Expert Rev Hematol (2010) 0.75
Predicting of Venous Thromboembolism for Patients Undergoing Gynecological Surgery. Medicine (Baltimore) (2015) 0.75
Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 16.17
Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet (2008) 9.10
The Scottish Record Linkage System. Health Bull (Edinb) (1993) 8.06
Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med (2000) 7.62
British Thoracic Society guidelines for the management of suspected acute pulmonary embolism. Thorax (2003) 5.83
The Million Women Study: design and characteristics of the study population. The Million Women Study Collaborative Group. Breast Cancer Res (1999) 3.34
Venous thromboembolism associated with hip and knee replacement over a ten-year period: a population-based study. J Bone Joint Surg Br (2005) 2.71
Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty. Arch Intern Med (1998) 2.58
Insufficient duration of venous thromboembolism prophylaxis after total hip or knee replacement when compared with the time course of thromboembolic events: findings from the Global Orthopaedic Registry. J Bone Joint Surg Br (2007) 2.53
Cancer and venous thromboembolism. Lancet Oncol (2005) 2.38
Postoperative pulmonary embolism after hospital discharge. An underestimated risk. Arch Surg (1992) 2.33
Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom. Arch Intern Med (2007) 1.95
Frequency and timing of clinical venous thromboembolism after major joint surgery. J Bone Joint Surg Br (2006) 1.56
Pulmonary embolism and its prophylaxis following the Charnley total hip replacement. Clin Orthop Relat Res (1977) 1.26
Patients and procedures in short-stay independent hospitals in England and Wales, 1997-1998. J Public Health Med (2000) 1.21
Cancer and venous thromboembolism: scope of the problem. Cancer Control (2005) 1.20
Self-reported information on joint replacement and cholecystectomy agrees well with that in medical records. J Clin Epidemiol (2007) 1.11
Risk of venous thromboembolism in patients undergoing cancer surgery and options for thromboprophylaxis. J Surg Oncol (2007) 1.08
Getting a validated guideline into local practice: implementation and audit of the SIGN guideline on the prevention of deep vein thrombosis in a district general hospital. Scott Med J (1998) 1.05
Cancer and venous thromboembolism: prevention, treatment and survival. J Thromb Thrombolysis (2007) 1.02
Implementation of a national guideline on prophylaxis of venous thromboembolism: a survey of acute services in Scotland. Thromboembolism Prevention Evaluation Study Group. Health Bull (Edinb) (1999) 0.97
Day-care or short-stay surgery and venous thromboembolism. J Thromb Haemost (2003) 0.96
Day surgery and thromboembolic complications: time for structured assessment and prophylaxis. Curr Opin Anaesthesiol (2007) 0.95
Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study. Lancet (2012) 15.74
Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med (2012) 11.83
Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer. Arch Intern Med (2009) 10.27
Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24. Nat Genet (2007) 9.88
Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ (2007) 8.00
The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UK. Lancet (2012) 7.28
Moderate alcohol intake and cancer incidence in women. J Natl Cancer Inst (2009) 6.21
Hypoglycemia and risk of death in critically ill patients. N Engl J Med (2012) 6.17
Endometrial cancer and hormone-replacement therapy in the Million Women Study. Lancet (2005) 5.20
Oral bisphosphonates and risk of cancer of oesophagus, stomach, and colorectum: case-control analysis within a UK primary care cohort. BMJ (2010) 4.92
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. Lancet (2016) 4.49
Cohort profile: the 45 and up study. Int J Epidemiol (2007) 4.37
Ovarian cancer and hormone replacement therapy in the Million Women Study. Lancet (2007) 4.34
Breast cancer risk in relation to the interval between menopause and starting hormone therapy. J Natl Cancer Inst (2011) 4.14
Evidence from randomised trials on the long-term effects of hormone replacement therapy. Lancet (2002) 3.70
Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer. JAMA (2007) 3.62
UK cancer survival statistics. BMJ (2010) 3.44
The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations. Gastroenterology (2008) 3.35
Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis. Lancet Oncol (2006) 3.12
Coronary artery calcification screening: estimated radiation dose and cancer risk. Arch Intern Med (2009) 3.05
Height and cancer incidence in the Million Women Study: prospective cohort, and meta-analysis of prospective studies of height and total cancer risk. Lancet Oncol (2011) 3.01
Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer And Nutrition (EPIC). Int J Cancer (2004) 2.96
Breast cancer and abortion: collaborative reanalysis of data from 53 epidemiological studies, including 83?000 women with breast cancer from 16 countries. Lancet (2004) 2.80
Inequalities in reported use of breast and cervical screening in Great Britain: analysis of cross sectional survey data. BMJ (2009) 2.77
Cervical cancer and use of hormonal contraceptives: a systematic review. Lancet (2003) 2.71
Gene-environment interactions in 7610 women with breast cancer: prospective evidence from the Million Women Study. Lancet (2010) 2.51
Fall in human papillomavirus prevalence following a national vaccination program. J Infect Dis (2012) 2.51
Mobile phone use and risk of brain neoplasms and other cancers: prospective study. Int J Epidemiol (2013) 2.45
Quality, quantity and harmony: the DataSHaPER approach to integrating data across bioclinical studies. Int J Epidemiol (2010) 2.44
Incidence of breast cancer and its subtypes in relation to individual and multiple low-penetrance genetic susceptibility loci. JAMA (2010) 2.20
Intake of animal products and stroke mortality in the Hiroshima/Nagasaki Life Span Study. Int J Epidemiol (2003) 2.11
Decrease in breast cancer incidence following a rapid fall in use of hormone replacement therapy in Australia. Med J Aust (2008) 2.06
Body mass index and risk of liver cirrhosis in middle aged UK women: prospective study. BMJ (2010) 2.01
Cervical cancer in Australia and the United Kingdom: comparison of screening policy and uptake, and cancer incidence and mortality. Med J Aust (2006) 1.92
Prescribing of hormone therapy for menopause, tibolone, and bisphosphonates in women in the UK between 1991 and 2005. Eur J Clin Pharmacol (2007) 1.88
Resuscitation fluid use in critically ill adults: an international cross-sectional study in 391 intensive care units. Crit Care (2010) 1.87
Obesity and thyroid cancer risk among U.S. men and women: a pooled analysis of five prospective studies. Cancer Epidemiol Biomarkers Prev (2011) 1.86
Changes over calendar time in the risk of specific first AIDS-defining events following HIV seroconversion, adjusting for competing risks. Int J Epidemiol (2002) 1.79
Nonradiation risk factors for thyroid cancer in the US Radiologic Technologists Study. Am J Epidemiol (2009) 1.74
Comparison of various characteristics of women who do and do not attend for breast cancer screening. Breast Cancer Res (2001) 1.73
Nonclassic lipoid congenital adrenal hyperplasia masquerading as familial glucocorticoid deficiency. J Clin Endocrinol Metab (2009) 1.68
Declining incidence of contralateral breast cancer in the United States from 1975 to 2006. J Clin Oncol (2011) 1.67
The spectrum of human immunodeficiency virus-associated cancers in a South African black population: results from a case-control study, 1995-2004. Int J Cancer (2008) 1.63
Factors associated with low immunity to rubella infection on antenatal screening. Aust N Z J Obstet Gynaecol (2005) 1.60
Body mass index, surgery, and risk of venous thromboembolism in middle-aged women: a cohort study. Circulation (2012) 1.60
Total cholesterol and cancer risk in a large prospective study in Korea. J Clin Oncol (2011) 1.59
EPIC-Heart: the cardiovascular component of a prospective study of nutritional, lifestyle and biological factors in 520,000 middle-aged participants from 10 European countries. Eur J Epidemiol (2007) 1.59
Marital status and ischemic heart disease incidence and mortality in women: a large prospective study. BMC Med (2014) 1.58
Gynecologic cancer as a "sentinel cancer" for women with hereditary nonpolyposis colorectal cancer syndrome. Obstet Gynecol (2005) 1.50
Fracture incidence in relation to the pattern of use of hormone therapy in postmenopausal women. JAMA (2004) 1.50
Antibodies against malaria and Epstein-Barr virus in childhood Burkitt lymphoma: a case-control study in Uganda. Int J Cancer (2008) 1.49
Lifetime body size and reproductive factors: comparisons of data recorded prospectively with self reports in middle age. BMC Med Res Methodol (2011) 1.48
Intravenous fluids in adults undergoing surgery. BMJ (2009) 1.45
Diabetes and modifiable risk factors for cardiovascular disease: the prospective Million Women Study. Eur J Epidemiol (2008) 1.42
Hormone therapy and recurrence of venous thromboembolism among postmenopausal women. Menopause (2011) 1.41
Validity of self-reported height and weight and derived body mass index in middle-aged and elderly individuals in Australia. Aust N Z J Public Health (2011) 1.41
Further evidence for promoting transdermal estrogens in the management of postmenopausal symptoms. Menopause (2011) 1.40
Efficacy of interventions to increase the uptake of chlamydia screening in primary care: a systematic review. BMC Infect Dis (2011) 1.34
The sero-epidemiology of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in adults with cancer in Uganda. Int J Cancer (2003) 1.34
Alcohol intake and breast cancer risk: the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Causes Control (2007) 1.33
Reproducibility of a short semi-quantitative food group questionnaire and its performance in estimating nutrient intake compared with a 7-day diet diary in the Million Women Study. Public Health Nutr (2005) 1.30
Ionizing radiation and the risk of brain and central nervous system tumors: a systematic review. Neuro Oncol (2012) 1.27
Phenotypic diversity in patients with multiple serrated polyps: a genetics clinic study. Int J Colorectal Dis (2010) 1.27
Comparison of the effects of genetic and environmental risk factors on in situ and invasive ductal breast cancer. Int J Cancer (2011) 1.25
Cancer incidence following treatment for infertility at a clinic in the UK. Hum Reprod (2002) 1.24
Risk factors for Kaposi's sarcoma: a case-control study of HIV-seronegative people in Uganda. Int J Cancer (2003) 1.24